secwatch.observer — SEC 8-K summary
======================================

Issuer:     Edwards Lifesciences Corp (EW)
CIK:        0001099800
Form:       8-K
Filed at:   2021-07-15T23:59:59+00:00
Accession:  0001193125-21-216533
Event type: other_material
Sentiment:  neutral
Materiality: 0.30
Item codes: 5.03, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Edwards Lifesciences amends bylaws to allow virtual meetings and exclusive federal forum
--------------------------------------------------------------------------------

- Board adopted amended bylaws on July 15, 2021, authorizing virtual-only stockholder meetings and electronic delivery of notices.
- Advance notice provisions now limit director nominees to the number of seats up for election and require nominator to be a stockholder of record.
- Exclusive forum clause designates federal district courts for claims arising under the Securities Act of 1933.
- Electronic proxies, written consents, and electronic signatures are explicitly permitted in accordance with Delaware law updates.
- Stock certificates may now be signed by any two authorized officers, removing prior specified officer combinations.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1099800/000119312521216533/0001193125-21-216533-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1099800/000119312521216533/d111792d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-21-216533

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer